Aier Eye Hospital Hits Day Low of CNY 8.62 Amid Price Pressure

Aier Eye Hospital Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.66% on July 17, 2026. The stock reached an intraday low of CNY 8.62, reflecting a challenging trading environment. Over the past year, Aier Eye Hospital has faced significant headwinds, with a total return of -30.5%, contrasting sharply with the China Shanghai Composite's gain of 7.03% during the same period. Despite the recent downturn, the company reported a strong operating cash flow of CNY 5,918.28 million, marking a positive financial metric. Additionally, the raw material costs have decreased by 3.48% year-over-year, which may provide some relief in operational expenses. The company's return on equity stands at 15.58%, although it is accompanied by a relatively high price-to-book ratio of 2.87. In the broader context, Aier Eye Hospital's performance has been underwhelming over various time frames, including a staggering 86.67% decline over the past five years. As a large-cap player in the Pharmaceuticals & Biotechnology industry, the company continues to navigate a complex market landscape.